Sprint Bioscience AB (publ) (FRA:5JA1)
Germany
· Delayed Price · Currency is EUR 0.1290
+0.0060 (4.88%)
At close: Dec 4, 2025
Sprint Bioscience AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 10.95 | 25.06 | 49.93 | 29.49 | 70.64 | 27.08 | Upgrade
|
| Cash & Short-Term Investments | 10.95 | 25.06 | 49.93 | 29.49 | 70.64 | 27.08 | Upgrade
|
| Cash Growth | -65.48% | -49.82% | 69.31% | -58.25% | 160.92% | 223.09% | Upgrade
|
| Accounts Receivable | - | - | 0.8 | 0.01 | 0.02 | 1.33 | Upgrade
|
| Other Receivables | 6.45 | 12.19 | 7.14 | 5.38 | 5.28 | 3.06 | Upgrade
|
| Receivables | 6.45 | 12.19 | 7.94 | 5.39 | 5.29 | 4.39 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 0.81 | Upgrade
|
| Total Current Assets | 17.4 | 37.24 | 57.87 | 34.88 | 75.94 | 32.27 | Upgrade
|
| Property, Plant & Equipment | 3.94 | 4.72 | 4.38 | 2.37 | 2.99 | 0.87 | Upgrade
|
| Long-Term Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.05 | 0.08 | 0.12 | 0.16 | 0.2 | Upgrade
|
| Total Assets | 21.44 | 42.06 | 62.38 | 37.42 | 79.14 | 33.4 | Upgrade
|
| Accounts Payable | 3.3 | 5.44 | 5.71 | 3.73 | 2.92 | 3.4 | Upgrade
|
| Accrued Expenses | - | 4.7 | 3.37 | 4.43 | 4.54 | 7.52 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 10 | Upgrade
|
| Current Unearned Revenue | - | 11.23 | 12.32 | - | - | - | Upgrade
|
| Other Current Liabilities | 12.07 | 11.42 | 13.21 | 1.07 | 1.22 | 3.33 | Upgrade
|
| Total Current Liabilities | 15.37 | 32.78 | 34.6 | 9.23 | 8.68 | 24.26 | Upgrade
|
| Total Liabilities | 15.37 | 32.78 | 34.6 | 9.23 | 8.68 | 24.26 | Upgrade
|
| Common Stock | 7.07 | 6.98 | 6.98 | 6.98 | 3.98 | 2.12 | Upgrade
|
| Additional Paid-In Capital | 291.81 | 273.67 | 273.9 | 273.87 | 258.97 | 174.44 | Upgrade
|
| Retained Earnings | -292.82 | -271.38 | -253.1 | -252.67 | -192.5 | -167.41 | Upgrade
|
| Shareholders' Equity | 6.06 | 9.27 | 27.77 | 28.19 | 70.45 | 9.14 | Upgrade
|
| Total Liabilities & Equity | 21.44 | 42.06 | 62.38 | 37.42 | 79.14 | 33.4 | Upgrade
|
| Total Debt | - | - | - | - | - | 10 | Upgrade
|
| Net Cash (Debt) | 10.95 | 25.06 | 49.93 | 29.49 | 70.64 | 17.08 | Upgrade
|
| Net Cash Growth | -65.48% | -49.82% | 69.31% | -58.25% | 313.73% | 103.76% | Upgrade
|
| Net Cash Per Share | 0.13 | 0.36 | 0.72 | 0.70 | 2.45 | 1.02 | Upgrade
|
| Filing Date Shares Outstanding | 105.52 | 69.82 | 69.82 | 69.8 | 39.84 | 21.21 | Upgrade
|
| Total Common Shares Outstanding | 105.52 | 69.82 | 69.82 | 69.8 | 39.84 | 21.21 | Upgrade
|
| Working Capital | 2.03 | 4.46 | 23.27 | 25.65 | 67.25 | 8.02 | Upgrade
|
| Book Value Per Share | 0.06 | 0.13 | 0.40 | 0.40 | 1.77 | 0.43 | Upgrade
|
| Tangible Book Value | 6.06 | 9.27 | 27.77 | 28.19 | 70.45 | 9.14 | Upgrade
|
| Tangible Book Value Per Share | 0.06 | 0.13 | 0.40 | 0.40 | 1.77 | 0.43 | Upgrade
|
| Machinery | - | 10.96 | 9.66 | 7.21 | 7.21 | 4.5 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.